Evidence map›Paper›PMID 28891343›Full record

ReviewExpert opinion on pharmacotherapy2018

Current and future contraceptive options for women living with HIV.

Rena C Patel, Elizabeth A Bukusi, Jared M Baeten

Abstract readReview
In one paragraph

Review in Expert opinion on pharmacotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. HIV Infections and Prevention in Women.Clinical obstetrics and gynecology · 2025
    Review
  4. Article
  5. Contraception in Medically Complex Adolescents and Young Adults.Open access journal of contraception · 2024
    Article
  6. Article
  7. Brief Report: Incidence and Correlates of Pregnancy in HIV-Positive Kenyan Sex Workers.Journal of acquired immune deficiency syndromes (1999) · 2020
    Article
  8. Article
  9. Article
  10. Clinical Pharmacology of Hormonal Emergency Contraceptive Pills.International journal of reproductive medicine · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rena C Patela Division of Allergy and Infectious Diseases, Department of Medicine , University of Washington , Seattle , WA , USA.
Elizabeth A Bukusib Centre for Microbiologic Research , Kenya Medical Research Institute ; Nairobi , Kenya.
Jared M Baetend Departments of Epidemiology, Global Health, and Medicine , University of Washington ; Seattle , WA , USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Investigating interactions between efavirenz-based antiretroviral therapy and contraceptive implantsK23AI120855 · NIAID · UNIVERSITY OF WASHINGTON · PI PATEL, RENA CHIMAN · 2015 to 2019
$850k
NIAID NIH HHS K23 AI120855NIAID NIH HHS P30 AI027757
6 · The paper itself

Abstract

introductionAmong women living with HIV, half of the pregnancies are unintended. Effective contraception can prevent unintended pregnancies and consequently reduce maternal mortality and perinatal transmission of HIV. While contraceptive options available for all women also apply to women living with HIV, specific considerations exist to the use of contraception by women living with HIV. AREAS COVERED: First, general principles guiding the use of contraception among women living with HIV are discussed, such as choice, method mix, relative effectiveness, and drug-drug interactions. Second, a detailed discussion of each contraceptive method and issues surrounding the use of that method, such as drug-drug interactions, follows. Third, future contraceptive options in advanced development for use by women or men are briefly discussed. EXPERT OPINION: Contraceptive methods available to all women should also be accessible to women living with HIV. When the relative effectiveness of a contraceptive method is reduced, for example due to drug-drug interactions with antiretrovirals, the method should still be made available to women living with HIV with the appropriate information sharing and counseling. Greater research on various aspects of contraceptive use by women living with HIV and more comprehensive testing of co-administration of hormonal contraceptives and common medications used by these women are warranted.

Indexed as

ContraceptionContraceptive AgentsCounselingDrug InteractionsFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalPregnancyContraceptive Agentsantiretroviralsdrug-drug interactionsFemale contraceptionmale contraceptionresource-limited settingswomen living with HIV

Identifiers

PMID28891343
PMCPMC5963879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.